September 2018 – Phoenix PharamLabs

Pain Medicine is Evolving – A Non-Addictive Opioid?

PPLadmin2020-12-10T19:38:27+00:00

A non-addictive opioid under development by Phoenix PharmaLabs (Utah), PPL-103, has demonstrated the potential to be a treatment for opioid, as well as cocaine, addictions, as published in a poster by Lawrence Toll, PhD, professor of biomedical science at the Charles E. Schmidt College of Medicine at Florida Atlantic University, and chief neuropharmacologist of Phoenix [...]

Pain Medicine is Evolving – A Non-Addictive Opioid?PPLadmin2020-12-10T19:38:27+00:00

How to fight drug addiction: the shift to prescription drugs

PPLadmin2020-12-10T19:42:00+00:00

Full Article

How to fight drug addiction: the shift to prescription drugsPPLadmin2020-12-10T19:42:00+00:00

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential

PPLadmin2020-12-10T19:45:37+00:00

Full Article

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse PotentialPPLadmin2020-12-10T19:45:37+00:00

One Stepfather’s Quest: The Search For An Opioid That Won’t Lead To Addiction

PPLadmin2020-12-10T19:50:44+00:00

Full Article

One Stepfather’s Quest: The Search For An Opioid That Won’t Lead To AddictionPPLadmin2020-12-10T19:50:44+00:00

Phoenix PharmaLabs Exec Describes Novel Non-Addictive Opioid

PPLadmin2020-12-10T20:01:02+00:00

Full Article

Phoenix PharmaLabs Exec Describes Novel Non-Addictive OpioidPPLadmin2020-12-10T20:01:02+00:00

Research Declares Phoenix PharmaLabs’ Opioid PPL-103 Safe

PPLadmin2020-12-10T19:56:57+00:00

Full Article

Research Declares Phoenix PharmaLabs’ Opioid PPL-103 SafePPLadmin2020-12-10T19:56:57+00:00